Nearly 70% of participants who self-administered acupressure therapy experienced improved levels of fatigue.
As breast cancer survivorship increases, NPs have taken on long-term patient care.
Extending adjuvant aromatase inhibitor treatment can decrease disease recurrence and increase survival in breast cancer patients.
Fruit intake in adolescence may be associated with decreased breast cancer rates in adulthood.
The combination of tomosynthesis and digital mammography screening may benefit women with heterogeneously dense breasts.
50% of women studied met the American Cancer Society requirements for early mammography screening.
Despite the guideline, clinicians may choose to order MRI's for patients with dense breasts.
Primary care clinicians should be proficient at assessing the potential for hereditary breast cancer risk in their patients.
In an update to its 2009 recommendations, the U.S. Preventive Services Task Force has presented its final guidelines on mammography screening for breast cancer.
Denosumab may reduce the risk of fracture in women with breast cancer on aromatase inhibitor therapyJanuary 06, 2016
Denosumab has been shown to reduce fracture risk in women with breast cancer with bone metastases.
False-positive results on a screening mammogram are associated with a greater risk of developing breast cancer in the 10 years following the result.
A new study of women with at least 2 risk factors for breast cancer found that ultrasound and mammography have similar breast cancer detection rates.
Postmenopausal women especially former smokers who quit within the last 20 years have an increased risk of postmenopausal breast cancer associated with periodontal disease.
In a study of over 278,000 patients with stage 1 through stage 3 breast cancer, African American women had the lowest rate of pathologic complete response.
Digital screening mammography is as accurate without computer-aided detection (CAD) as it is with the technology.
Data released by the American Cancer Society show that, for the first time, breast cancer incidence is nearly identical in black and white women.
New guidelines from the American Cancer Society suggest that to combat overdiagnosis, women begin mammography screening for breast cancer at age 45 and continue yearly through age 54 before transitioning to a biannual screening plan.
Women who receive genetic counseling prior to undergoing BRCA testing display more knowledge of both the testing process and of the potential results.
For breast cancer survivors, acupuncture was more effective than gabapentin for treating hot flashes.
Light to moderate alcohol intake increased the risk of alcohol-related cancers in women.
For hereditary breast, ovarian cancer, multigene testing can influence clinical treatment options.
The CDC reports that screening rates for colorectal, breast, and cervical cancer have dropped in recent years.
Variants in the KLF4 gene most strongly linked to estrogen receptor-positive disease.
A patient was referred for a mammogram, but clinicians fail to follow up on the report.
Only the consumption of fruits and vegetables was significantly higher in the intervention group.
Researchers found no association between patients with clinician-diagnosed migraines and invasive breast cancer.
Treatment-related discomfort, swelling helped by the approaches in two studies.
One study of 6,459 U.S. women aged 55 years to 81 years revealed that the use of alendronate or placebo did not affect the proportion of women who developed breast cancer (1.8% and 1.5%, respectively).
Patients overdue for screening were more likely to return for a mammogram after their family health-care provider sent personalized letter and postcard reminders.
In women with newly diagnosed breast cancer, the optimal time for referral to cancer genetic specialists is unknown.